Literature DB >> 11836400

Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice.

Ingunn M Stromnes1, Ulf Dittmer, Ton N M Schumacher, Koen Schepers, Ronald J Messer, Leonard H Evans, Karin E Peterson, Brent Race, Kim J Hasenkrug.   

Abstract

The current studies demonstrate complex and seemingly contradictory effects by gamma interferon (IFN-gamma) on Friend virus (FV) infection. Both temporal and tissue-specific effects were observed. During the first week of infection, IFN-gamma-deficiency caused increased levels of FV infection in multiple tissues. Surprisingly, however, by 2 weeks postinfection, IFN-gamma-deficient mice had significantly lower levels of infection in both the spleen and bone marrow compared to wild-type mice. The rapid reduction of virus in the IFN-gamma-deficient mice correlated with a more rapid virus-neutralizing antibody response than was observed in the wild-type mice. Furthermore, the virus-neutralizing antibody response in wild-type mice could be accelerated by ablation of their IFN-gamma response. Although the IFN-gamma-deficient mice developed an accelerated virus-neutralizing antibody response, they did not class-switch to immunoglobulin G class immunoglobulins nor could they maintain long-term virus-neutralizing antibody titers. Eventually, all of the IFN-gamma-deficient mice failed to keep persistent virus in check and developed fatal FV-induced erythroleukemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836400      PMCID: PMC153801          DOI: 10.1128/jvi.76.5.2225-2232.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  Cytokine-induced viral purging--role in viral pathogenesis.

Authors:  L G Guidotti; F V Chisari
Journal:  Curr Opin Microbiol       Date:  1999-08       Impact factor: 7.934

Review 2.  Noncytolytic control of viral infections by the innate and adaptive immune response.

Authors:  L G Guidotti; F V Chisari
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Fv2 encodes a truncated form of the Stk receptor tyrosine kinase.

Authors:  D A Persons; R F Paulson; M R Loyd; M T Herley; S M Bodner; A Bernstein; P H Correll; P A Ney
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

4.  An IFN-gamma-dependent pathway plays a critical role in the pathogenesis of murine immunodeficiency syndrome induced by LP-BM5 murine leukemia virus.

Authors:  S Uehara; Y Hitoshi; F Numata; M Makino; M Howard; T Mizuochi; K Takatsu
Journal:  Int Immunol       Date:  1994-12       Impact factor: 4.823

Review 5.  Host-range control of a retroviral disease: Friend erythroleukemia.

Authors:  M E Hoatlin; D Kabat
Journal:  Trends Microbiol       Date:  1995-02       Impact factor: 17.079

6.  Deletions in one domain of the Friend virus-encoded membrane glycoprotein overcome host range restrictions for erythroleukemia.

Authors:  M E Hoatlin; F E Ferro; R W Geib; M T Fox; S L Kozak; D Kabat
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  An essential role for type 1 interferon-gamma in terminating persistent viral infection.

Authors:  A Tishon; H Lewicki; G Rall; M Von Herrath; M B Oldstone
Journal:  Virology       Date:  1995-09-10       Impact factor: 3.616

8.  Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin.

Authors:  R T Means; S B Krantz; J Luna; S A Marsters; A Ashkenazi
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

9.  Interferon-gamma induces resistance in primary monocytes against human immunodeficiency virus type-1 infection.

Authors:  S Dhawan; A Heredia; R B Lal; L M Wahl; J S Epstein; I K Hewlett
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

10.  In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).

Authors:  R T Gazzinelli; N A Giese; H C Morse
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  19 in total

1.  Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs.

Authors:  Anke R M Olbrich; Simone Schimmer; Klaus Heeg; Koen Schepers; Ton N M Schumacher; Ulf Dittmer
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.

Authors:  Gennadiy Zelinskyy; Shelly J Robertson; Simone Schimmer; Ronald J Messer; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.

Authors:  Wibke Bayer; Matthias Tenbusch; Ruth Lietz; Lena Johrden; Simone Schimmer; Klaus Uberla; Ulf Dittmer; Oliver Wildner
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

4.  CD137 costimulation of CD8+ T cells confers resistance to suppression by virus-induced regulatory T cells.

Authors:  Shelly J Robertson; Ronald J Messer; Aaron B Carmody; Robert S Mittler; Christopher Burlak; Kim J Hasenkrug
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

5.  Resistance to friend virus-induced erythroleukemia in W/W(v) mice is caused by a spleen-specific defect which results in a severe reduction in target cells and a lack of Sf-Stk expression.

Authors:  Aparna Subramanian; Hami E Teal; Pamela H Correll; Robert F Paulson
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.

Authors:  Tatsuya Ogawa; Sachiyo Tsuji-Kawahara; Takae Yuasa; Saori Kinoshita; Tomomi Chikaishi; Shiki Takamura; Haruo Matsumura; Tsukasa Seya; Toshihiko Saga; Masaaki Miyazawa
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

7.  Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies.

Authors:  Mar Naranjo-Gomez; Jennifer Lambour; Marc Piechaczyk; Mireia Pelegrin
Journal:  JCI Insight       Date:  2018-05-03

8.  Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responses.

Authors:  Edward P Browne
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy.

Authors:  Henri-Alexandre Michaud; Tiphanie Gomard; Laurent Gros; Kevin Thiolon; Roudaina Nasser; Chantal Jacquet; Javier Hernandez; Marc Piechaczyk; Mireia Pelegrin
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

10.  Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame.

Authors:  Melanie R Rutkowski; On Ho; William R Green
Journal:  Virology       Date:  2009-06-18       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.